Margarethe Konik

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 248 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients

Constantin J. Thieme, Moritz Anft, Krystallenia Paniskaki et al. · Cell Reports Medicine · 2020 · 188 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19

Johanna Reinold, Farnoush Farahpour, Christian Fehring et al. · Frontiers in Cellular and Infection Microbiology · 2021 · 89 citations · Full text

Life Sciences, Immunology, Microbiology +17

Tumor vascularization and histopathologic regression of soft tissue sarcomas treated with isolated limb perfusion with TNF‐α and melphalan

Florian Grabellus, Corinna Kraft, Sien‐Yi Sheu‐Grabellus et al. · Journal of Surgical Oncology · 2011 · 43 citations

Medicine, Oncology, Pathology +17

A possible role of immunopathogenesis in COVID-19 progression

Moritz Anft, Krystallenia Paniskaki, Arturo Blazquez‐Navarro et al. · medRxiv · 2020 · 43 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17